News
Investor's Business Daily on MSN18m
Eli Lilly Slumps 5% On Profit Guidance Cut Despite Mounjaro, Zepbound BeatsEli Lilly stock fell Thursday after the drugmaker cut its full-year profit guidance despite a first-quarter beat.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback